Thursday, April 18, 2019

rewriting the nytimes because there is a step prior

inadequately discussed and illuminated





Stephanie Spoor, center, with her husband, Gregory, left, during a bedside wedding ceremony of her son, Zack, to his new wife, Carley (right), at Northwestern Memorial Hospital in Chicago. Ms. Spoor died just a few days later.CreditSpoor family photo

Image
Stephanie Spoor, center, with her husband, Gregory, left, during a bedside wedding ceremony of her son, Zack, to his new wife, Carley (right), at Northwestern Memorial Hospital in Chicago. Ms. Spoor died just a few days later.CreditCreditSpoor family photo
Gregory Spoor got the distressing news about his wife on the morning of Jan. 16 while standing outside her room in the intensive care unit at Northwestern Memorial Hospital in Chicago. The doctor explained that Stephanie Spoor, 64, had contracted a “rare, very rare, fungus.”
predicate lupus
treated how?
the immune system of a lupus patient may be reordered in accordance with the teachings of  denise l faustman uspto.gov inventor search faustman faustmanlab.org  pubmed.org faustman

if the immune system was not impaired by lupus and the treatment thereof would the patient have had a chance to survive thefungus in the bloodstream?


as usual the nyt lacks clarity and glosses over the predicate condition, lupus

perhaps the fungus kills healthy people as well when it is injected into the bloodstream?  it might just take longer?

in any event chicago lacks the best treatmrnt ir remediation for lupus ehic is found in boston




The physician said the fungus was called Candida auris, and it appeared to have entered her bloodstream through a catheter or other intravenous line during her treatment. Mr. Spoor sent a text to the couple’s four children.
“Hey guys, I’m very sorry to do this via text but you need to know and not fair to wait until all of us are together,” he wrote. “The fungus mom has is the worst possible and can be terminal.”
He added: “It is a day to day issue so I don’t have any more answers or info at this time.”
Mr. Spoor, 67, an executive at a plumbing equipment company, wasn’t the only one with few answers. C. auris, a germ that typically is resistant to major antifungal medications, has been quietly confounding doctors, hospitals and infectious disease scientists around the world.

ADVERTISEMENT
First identified in the ear of a woman in Japan in 2009 (“auris” is Latin for “ear”), the germ has spread around the globe, mostly appearing in hospitals and nursing homes, where it afflicts people with weakened immune systems.
Nearly 600 cases of C. auris have been reported in the United States, the majority of them in New York, New Jersey and Illinois. According to the Centers for Disease Control and Prevention, nearly half of people who contract the illness die within 90 days. But the true death rate is difficult to quantify because most patients have other medical conditions and their deaths may be attributed to other causes.
About 90 percent of C. auris strains are resistant to at least one drug, and 30 percent are resistant to two or more of the three major classes of antifungal drugs. However, on Tuesday, the C.D.C. confirmed that it has learned in the last month of the first known cases in the United States of so-called “pan-resistant” C. auris — a strain resistant to all major antifungals, said Dr. Tom Chiller, head of the agency’s fungal division, in an interview.
Such cases have been seen in several countries, including India and South Africa, but the two new cases, from New York State, have not been reported previously. Dr. Chiller said that it appeared that, in each case, the germ evolved during treatment and became pan-resistant, confirming a fear that the infection will continue to develop more effective defenses.

No comments:

Post a Comment